Featuring the return of ‘Unreported clinical trial of the week’, exciting opportunities in the age of digital publishing and a new pilot to make comments on preprints publicly available
Featuring a sneak preview of responses to the Health Research Authority ‘Make it Public’ consultation, an investigation into researchers’ communication with study participants and the worldwide spread of endorsements for the Open Pharma position statement on open access
Featuring the launch of the Open Pharma position statement on open access, an introduction to the Open Science in Action Inaugural Symposium and a call to action for the UK government to do more to ensure transparent clinical trial reporting.
ORCID is part of the wider digital infrastructure needed for researchers to share information on a global scale. ORCID enables transparent and trustworthy connections between researchers, their contributions, and affiliations by providing an identifier for individuals to use with their name as they engage in research, scholarship and innovation activities. The Open Pharma community is … Continue reading Guest post: ORCID adoption in the pharma community
Featuring researchers’ fears surrounding clinical trial registries, a roundup of the events planned for Open Access Week 2019 and the release of the Open Pharma Charter
Featuring the upcoming MedComms Brunch Meeting on open access, an investigation into the future of open access publishing, news from the third Asia Pacific Meeting of ISMPP and the scientific community’s toxic definition of success
Featuring the Open Pharma and Pint of Science crossover event, a new pilot project to facilitate the transparent review of preprints and the results from a Nature poll on coercive citations
Featuring the growing traction of Registered Reports, an investigation into the inconsistent role of a peer reviewer, unusual citation patterns in some manuscripts and a new Plan S toolkit
Featuring the pros and cons of ‘patient-orientated research’, a new addition to the Medical Publishing and Insights Practices (MPIP) open access toolkit and an update on Plan S.
Featuring concerns over financing ‘pay to publish’ models, a fresh demand for clinical trial transparency sanctions, and how one highly cited article may influence a journal’s impact factor and a researcher’s career progression.